Thursday Morning Headlines

Yesterday was dominated by Biogen's news on their Alzheimer drug, but there was other news including Sarepta getting slapped with a clincial hold, Gilead CEO stepping down and, although not Life Science related, Facebook getting crushed after their earnings.  Here is what I'm reading: Yesterday afternoon Eisai & Biogen Revealed Promising Alzheimer’s Data But Questions … Continue reading Thursday Morning Headlines

Wednesday Reads

I’m off to Boston this afternoon for a CFO conference on Thursday and Friday and tonight I will be the ACG Dealfest, let me know if you will be attending.  This is what I’m reading before I head out: Runaway Billionaire: Meet The CEO Whose Company Descended Into Fraud, Embezzlement and Betrayal New implantable device … Continue reading Wednesday Reads

2018 Medtech Conference Recap

I had the pleasure of attending the Medtech Conference on May 31st in Minneapolis that was put on by Healthegy.  This was a one day event and the goal was to bring together startup and early stage companies, large corporations, investors, academia, and of course service providers like myself that cater to the industry. For … Continue reading 2018 Medtech Conference Recap